ePrints

105O - Osimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC: The AURA LM study

Lookup NU author(s): Professor Alastair GreystokeORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Ahn M-J, Chiu C-H, Cheng Y, Han J-Y, Goldberg SB, Greystoke A, Crawford J, Zhao Y, Huang X, Johnson M, Vishwanathan K, Mendoza-Naranjo A, Mok TSK

Publication type: Article

Publication status: Published

Journal: Annals of Oncology

Year: 2019

Volume: 30

Issue: Supplement 2

Pages: ii48

Print publication date: 01/04/2019

Online publication date: 24/02/2020

Acceptance date: 02/04/2018

Date deposited: 09/03/2020

ISSN (print): 0923-7534

ISSN (electronic): 1569-8041

Publisher: Oxford University Press

URL: https://doi.org/10.1093/annonc/mdz063.003

DOI: 10.1093/annonc/mdz063.003

Altmetrics

Funding

Share